The Journal of Urology
Volume 176, Issue 4 , Pages 1299-1306 , October 2006

Prevention of Benign Prostatic Hyperplasia Disease

  • Leonard S. Marks

      Affiliations

    • Urological Sciences Research Foundation and Department of Urology, Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California
    • Corresponding Author InformationCorrespondence: Urological Sciences Research Foundation, 3831 Hughes Ave., Suite 701, Culver City, California 90232 (telephone: 310-559-9800; FAX: 310-559-7821).
    • Financial interest and/or other relationship with Merck, Beckman-Coulter, Pfizer, Sanofi, Watson, Gen-Probe, GlaxoSmithKline and Diagnostic Ultrasound.
    • ,
  • Claus G. Roehrborn

      Affiliations

    • Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas
    • ,
  • Gerald L. Andriole

      Affiliations

    • Division of Urologic Surgery, Washington University School of Medicine, St. Louis, Missouri

Received 19 September 2005

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by an unrestricted educational grant from GlaxoSmithKline, Philadelphia, Pennsylvania.

PII: S0022-5347(06)01390-5

doi: 10.1016/j.juro.2006.06.022

The Journal of Urology
Volume 176, Issue 4 , Pages 1299-1306 , October 2006

Article Tools

* Image Usage & Resolution